According to a recent study, the calcimimetic drug cinacalcet may have the potential to correct the hypercalcemia caused by the inactivating GNA11 Phe220Ser gene mutation, perhaps by enhancing the signalling process through the wild-type copy of Gα11 protein [27]. The gene discussed is GNA11; the disease is hypercalcemia disease.